<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04196569</url>
  </required_header>
  <id_info>
    <org_study_id>19-05020251</org_study_id>
    <nct_id>NCT04196569</nct_id>
  </id_info>
  <brief_title>Trifocal Intraocular Lens (IOL) Aberrometry Outcomes</brief_title>
  <official_title>Spectacle Independence After Implantation of Trifocal and Trifocal Toric Intraocular Lenses Using Intraoperative Aberrometry: A Prospective Analysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Weill Medical College of Cornell University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Weill Medical College of Cornell University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to evaluate subject outcomes and spectacle independence with
      intraoperative aberrometry and trifocal IOL implantation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 12, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of spectacle independence (overall)</measure>
    <time_frame>1 month post-cataract surgery</time_frame>
    <description>This will be assessed by a Visual Quality Questionnaire, an 18 question multiple choice questionnaire to assess vision-related functioning. Grading scale: 0, no difficulty; 1, a little difficulty; 2, moderate difficulty; 3, quite difficult; 4, impossible to perform. Mean value(s) will be analyzed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage spectacle independence (overall)</measure>
    <time_frame>3 months post-cataract surgery</time_frame>
    <description>This will be assessed by a Visual Quality Questionnaire, an 18 question multiple choice questionnaire to assess vision-related functioning. Grading scale: 0, no difficulty; 1, a little difficulty; 2, moderate difficulty; 3, quite difficult; 4, impossible to perform. Mean value(s) will be analyzed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Spectacle independence for distance, intermediate and near</measure>
    <time_frame>1 month post-cataract surgery</time_frame>
    <description>This will be assessed by a Visual Quality Questionnaire, an 18 question multiple choice questionnaire to assess vision-related functioning. Grading scale: 0, no difficulty; 1, a little difficulty; 2, moderate difficulty; 3, quite difficult; 4, impossible to perform. Mean value(s) will be analyzed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spectacle independence for distance, intermediate and near</measure>
    <time_frame>3 months post-cataract surgery</time_frame>
    <description>This will be assessed by a Visual Quality Questionnaire, an 18 question multiple choice questionnaire to assess vision-related functioning. Grading scale: 0, no difficulty; 1, a little difficulty; 2, moderate difficulty; 3, quite difficult; 4, impossible to perform. Mean value(s) will be analyzed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spectacle independence subgroup analysis for subjects within 0.50 D spherical equivalent (SE)</measure>
    <time_frame>1 month post-cataract surgery</time_frame>
    <description>This will be assessed by a Visual Quality Questionnaire, an 18 question multiple choice questionnaire to assess vision-related functioning. Grading scale: 0, no difficulty; 1, a little difficulty; 2, moderate difficulty; 3, quite difficult; 4, impossible to perform. Mean value(s) will be analyzed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spectacle independence subgroup analysis for subjects within 0.50 D spherical equivalent (SE)</measure>
    <time_frame>3 months post-cataract surgery</time_frame>
    <description>This will be assessed by a Visual Quality Questionnaire, an 18 question multiple choice questionnaire to assess vision-related functioning. Grading scale: 0, no difficulty; 1, a little difficulty; 2, moderate difficulty; 3, quite difficult; 4, impossible to perform. Mean value(s) will be analyzed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Binocular, uncorrected distance visual acuity for patients within 0.50 D of intended target</measure>
    <time_frame>3 months post-cataract surgery</time_frame>
    <description>This will be measured by visual acuity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject satisfaction</measure>
    <time_frame>3 months post-cataract surgery</time_frame>
    <description>This will be assessed by a Visual Quality Questionnaire, an 18 question multiple choice questionnaire to assess vision-related functioning. Grading scale: 0, no difficulty; 1, a little difficulty; 2, moderate difficulty; 3, quite difficult; 4, impossible to perform. Mean value(s) will be analyzed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Uncorrected binocular and monocular visual acuity at all distances</measure>
    <time_frame>3 months post-cataract surgery</time_frame>
    <description>This will be measured by visual acuity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distribution of residual refractive error</measure>
    <time_frame>3 months post-cataract surgery</time_frame>
    <description>This will be measured by refractive error</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contrast sensitivity (binocular)</measure>
    <time_frame>1 month post-cataract surgery</time_frame>
    <description>This will be measured by contrast sensitivity testing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contrast sensitivity (binocular)</measure>
    <time_frame>3 months post-cataract surgery</time_frame>
    <description>This will be measured by contrast sensitivity testing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of subjects with &lt;=0.50 D of refractive cylinder</measure>
    <time_frame>1 month post-cataract surgery</time_frame>
    <description>This will be measured by refractive error</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of subjects with &lt;=0.50 D of refractive cylinder</measure>
    <time_frame>3 months post-cataract surgery</time_frame>
    <description>This will be measured by refractive error</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>trifocal intraocular lens</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Alcon Trifocal and Trifocal Toric Intraocular Lenses</intervention_name>
    <description>Panoptix Model #TFAT00 for the UV Absorbing Trifocal IOL. Torics:
TFAT30, TFAT40, TFAT50, TFAT60</description>
    <arm_group_label>trifocal intraocular lens</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with a diagnosis of visually-significant cataracts who meet the inclusion and
        exclusion criteria will be eligible for participation in this study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Able to consent to study and cataract surgery

          -  Visually significant cataract

          -  Potential post-operative visual acuity of 20/25 or better

          -  Age 18 years or older

        Exclusion Criteria:

          -  Ocular pathology contraindicated for trifocal IOLs including but not limited to
             diabetic retinopathy, age-related macular degeneration or other macular pathology,
             cornea guttata, corneal scarring, corneal ectasia, glaucoma with visual field loss

          -  Irregular astigmatism

          -  Prior corneal refractive surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ashley Brissette, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Weill Cornell Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Susan Herder, BA, PA-C</last_name>
    <phone>646-962-4118</phone>
    <email>herders@med.cornell.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Weill Cornell Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Herder, BA, PA-C</last_name>
      <phone>646-962-4118</phone>
      <email>herders@med.cornell.edu</email>
    </contact>
    <investigator>
      <last_name>Ashley Brissette, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 10, 2019</study_first_submitted>
  <study_first_submitted_qc>December 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 12, 2019</study_first_posted>
  <last_update_submitted>December 12, 2019</last_update_submitted>
  <last_update_submitted_qc>December 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>trifocal lens</keyword>
  <keyword>trifocal intraocular lens</keyword>
  <keyword>aberrometry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

